ArticleDrug delivery and translational research2022

Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.

Vishal C Gurumukhi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.